Back

Myocardial injury and heart failure biomarkers in acute intermittent porphyria

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Alternative imaging, serological, and vocal biomarkers in heart failure Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Krzysztof Jaworski

National Institute of Cardiology, Warsaw (Poland)

8 More presentations in this session

Presentation thumbnail
Exploring vocal biomarkers as non-invasive fine-tuning assays of cardiovascular health: heart failure model
Professor M. Yilmaz (Izmir, TR)
Abstract Slides Video
Presentation thumbnail
Do I sound sick? Self-perceived and objectively measured voice impairment in acutely decompensated heart failure: fist insights from the AHF-Voice study
Mr M. Bauser (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
PIRCHE-II: a new tool to predict rejection in cardiac transplantation?
Doctor G. Fischetti (Bari, IT)
Abstract Slides Video
Presentation thumbnail
Left ventricular myocardial work predicts clinical course in patients with heart failure with mildly reduced ejection fraction
Professor A. Chilingaryan (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Beyond conventional measures: left atrial reservoir strain as a superior prognostic marker for all-cause mortality in HFpEF
Doctor A. Attanasio (San Donato Milanese, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Alternative imaging, serological, and vocal biomarkers in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Swollen heart after Covid-19: temporary left ventricular wall thickening in acute intermittent porphyria
thumbnail
Congress Presentation
The potentially underestimated influence of atrial fibrillation on NT-proBNP in chest pain
thumbnail
Congress Presentation
Proteomic analysis of potential biomarkers of recent onset dilated cardiomyopathy for prediction of the therapy outcome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources